Role of gas chromatography-mass spectrometry with negative ion chemical ionization in clinical and forensic toxicology, doping control, and biomonitoring

Therapeutic Drug Monitoring

Volumn 24, Issue 2, 2002, Pages 247-254

  Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Biomonitoring; Clinical toxicology; Doping control; Drug; Forensic toxicology; Gas chromatography; Mass spectrometry; Negative ion chemical ionization

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; ANABOLIC AGENT; BENZODIAZEPINE DERIVATIVE; BUTORPHANOL; CANNABINOID; CHLOROPHENOL; CHLORPYRIFOS; CLEVIDIPINE; CLONAZEPAM; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUMAZENIL; FLUNITRAZEPAM; HALOGEN; HEXACHLOROCYCLOHEXANE; KETOPROFEN; LISINOPRIL; LORAZEPAM; METHYLPHENIDATE; MORPHINE; NALTREXONE; OPIATE DERIVATIVE; ORGANOCHLORINE DERIVATIVE; PESTICIDE; POLYCHLORINATED BIPHENYL; TEGAFUR; TRIAZOLAM; UNINDEXED DRUG; ZACOPRIDE;

BIOLOGICAL MONITORING; BONE; DERIVATIZATION; DOPING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HAIR; HUMAN; MASS SPECTROMETRY; METABOLITE; MUSCLE; NONHUMAN; PLASMA; POLLUTANT; PRIORITY JOURNAL; REVIEW; SWEAT; TOXICOLOGY;

DOPING IN SPORTS; DRUG MONITORING; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; TOXICOLOGY;

EID: 0036129817     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200204000-00007     Document Type: Review

References (79)

1. Computer-aided identifications of thin-layer chromatographic patterns in broadspectrum drug screening
2. Automated analysis of drugs in urine
3. Determination of illicit and/or abused drugs and compounds of forensic interest in biosamples by capillary electrophoresic/electrokinetic methods
4. Progress of capillary electrophoresis in therapeutic drug monitoring and clinical and forensic toxicology
5. Systematic toxicological analysis of drugs and their metabolites by gas chromatography-mass spectrometry
6. Determination of drugs of abuse in blood
7. Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine
8. Testing for drugs of abuse in saliva and sweat
9. Determination of drugs of abuse in meconium
10. Testing for drugs in hair. Critical review of chromatographic procedures since 1992
11. Detection of drugs of abuse in nails
12. Chromatographic procedures for determination of cannabinoids in biologic samples, with special attention to blood and alternative matrices like hair, saliva, sweat and meconium
13. Determination of Ecstasy components in alternative biologic specimens
14. Hair analysis for abused and therapeutic drugs
15. Testing hair for pharmaceuticals
16. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry
17. Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology or doping control
18. Systematic toxicological analysis of drugs and poisons in biosamples by hyphenated chromatographic and spectroscopic techniques
19. Chromatographic screening techniques in systematic toxicological analysis
20. Introduction to the application of capillary gas chromatography of performance-enhancing drugs in doping control
21. Screening procedures for simultaneous detection of several drug classes used in the high throughput toxicological analysis and doping control
22. What is the appropriate analytical strategy for effective management of intoxicated patients?
23. Hyphenated liquid chromatographic techniques in forensic toxicology
24. Liquid chromatography-mass spectrometry: Potential in forensic and clinical toxicology
25. Progress of liquid chromatography - Mass spectrometry in clinical and forensic toxicology
26. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: Gas chromatographic-mass spectrometric studies on rat liver microsomes and on human urine
27. Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fen-proporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay (FPIA)
28. Benzodiazepine analysis by negative chemical ionization gas chromatography/mass spectrometry
29. Gas chromatographic-tandem mass spectrometric determination of acetylsalicylic acid in human plasma after oral administration of low-dose aspirin and guaimesal
30. Detection of alprazolam in hair by negative ion chemical ionization mass spectrometry
31. Screening for forensically relevant benzodiazepines in human hair by gas chromatography-negative ion chemical ionization-mass spectrometry
32. Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry
33. Quantitative determination of butorphanol and its metabolites in human plasma by gas chromatography-electron capture negative-ion chemical ionization mass spectrometry
34. Determination of an ultrashort-acting antihypertensive dihydropyridine, clevidipine, in blood using capillary gas chromatography-mass spectrometry and of the primary metabolite using liquid chromatography and fluorescence detection
35. Quantitative determination of clonazepam in plasma by gas chromatography-negative ion chemical ionization mass spectrometry
36. Sweat testing for benzodiazepines
37. Determination of flumazenil in plasma by gas chromatography-negative ion chemical ionization mass spectrometry
38. Highly sensitive microplate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair
39. Determination of chronic flunitrazepam abuse by hair analysis using GC-MS-NCI
40. Stable isotope labeling and determination of ketroprofen in human plasma and urine by gas chromatography/negative ion chemical ionization mass spectrometry
41. Quantitative determination of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry
42. An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry
43. Detection and quantification of lorazepam in human hair by GC-MS/NCI in a case of traffic accident
44. Enantioselective gas chromatography-negative ion chemical ionization mass spectrometry for methylphenidate in human plasma
45. Simultaneous determination of moexipril and moexiprilat, its active metabolite, in human plasma by gas chromatography-negative- ion chemical ionization mass spectrometry
46. Analysis of unconjugated morphine, codeine, normorphine and morphine as glucuronides in small volumes of plasma from children
47. Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry
48. Hair analysis for nordiazepam and oxazepam by gas chromatography-negative-ion chemical ionization mass spectrometry
49. Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry
50. Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry
51. Testing human hair for cannabis. II. Identification of THC-COOH by GC-MS-NCI as a unique proof
52. Hair testing for cannabis in Spain and France: Is there a difference in consumption?
53. Detection of THCCOOH in hair by MSDNCI after HPLC clean-up
54. Detection of triazolam in skeletal remains buried for 4 years
55. Quantitative measurement of zacopride in human plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry
56. Determination of four anabolic steroid metabolites by gas chromatography/mass spectrometry with negative ion chemical ionization and tandem mass spectrometry
57. Determination of anabolic steroids by gas chromatography/negative-ion chemical ionization mass spectrometry and gas chromatography/negative-ion chemical ionization tandem mass spectrometry with heptafluorobutyric anhydride derivatization
58. Testing of the anabolic stanozolol in human hair by gas chromatography-negative ion chemical ionization mass spectrometry
59. Detection of stanozolol in hair by negative ion chemical ionization mass spectrometry
60. Serum total testosterone: Immunoassay compared with negative chemical ionization gas chromatography-mass spectrometry
61. Application of solid-phase microextraction and gas chromatography-mass spectrometry for the determination of chlorophenols in urine
62. Semiautomated preparation of 3,5,6-trichloro-2-pyridinol in human urine using a Zymate XP laboratory robot with quantitative determination by gas chromatography-negative-ion chemical ionization mass spectrometry
63. Determination of chlorpyrifos, chlorpyrifos oxon, and 3,5,6-trichloro-2-pyridinol in rat and human blood
64. Hexachlorocyclohexanes in human blood serum
65. Monitoring of polychlorinated biphenyls in human blood plasma: Methodological developments and influence of age, lactation, and fish consumption
66. Applicability of various brands of mixed-phase extraction columns for opiate extraction from blood and serum
67. Determination of methadone and its metabolites EDDP and EMDP in human hair by headspace solid-phase microextraction and gas chromatography-mass spectrometry
68. Improvement of sample preparation for the STA: Acceleration of acid hydrolysis and derivatization procedures by microwave irradiation
69. Methods for GC-MS
70. Screening proceduro for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry
71. GC-MS screening for detection of new antidepressants, hypnotics, neuroleptics, and their metabolites in urine developed using rat liver microsomes
72. Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography-mass spectrometry
73. Toxicologic aspects of heroin substitution treatment
74. Use of alternative specimens: Drugs of abuse in saliva and doping agents in hair